• Clemex announces its Financial Results for 2013

    20/08/2013 12:00:00 AM

    Montréal (Québec), August 20 2013 – Clemex Technologies Inc. (TSXV: CXG.A) announces its financial results for Fiscal Year ending April 30th, 2013. The Corporation ends this Fiscal Year with total sales of $5,884,631 in 2013 compared also to $5,939,016 in 2012. Gross margin increased by 2.1% allowing the Company to end this Fiscal Year with a net result of $101,302 compared to $43,467 in 2012.

    When asked to comment these results, President and CEO, Clement Forget declared the following: “In 2013, sales in most geographic areas served the Company well again this year. Sales abroad rose by 12.0% while they remained stable at $960,235 in Europe alone, compared to $945,769 in 2012. In United States, sales increased by 4.5%, from $2,449,154 in 2012 to $2,559,710 this year, while total sales for North America fell by 6.6% due to the substantial drop in sales in Canada, which ended at $1,266,814 this year compared to $1,651,814 in 2012. The decrease in sales in Canada is mostly due to a weak manufacturing sector activity and to less microscopes distribution sales in Eastern Canada. Consequently, total Company sales were slightly lower this year when compared to 2012. Finally, the strength of the Canadian dollar, which traded at parity with the U.S. dollar for most of the year, remains a key factor that has been undermining the Company’s overall sales as 75% of our sales worldwide are made in US dollars.”

    Mr. Forget continued: ” Various commercial activities were conducted during the 2013 fiscal year to promote the new Haematological analysis instrument. In addition, a private placement was concluded early this year with a German partner and client enabling the Company to raise $1,044,000. These funds will be used mostly to support new medical devices development and marketing activities. In fall of 2012, the Company opened a subsidiary in Martillac, France, located in its French partner facilities, RAL Diagnostics, to be closer to the European market, which provides excellent sales opportunities for Clemex instruments.


    Fiscal year ended

     April 30th, 2013

     April 30th, 2012





    5, 884,631





    Gross Margin

    3, 260,235



    55.4 %

    53.2 %




    Total Operating Expenses











    Net Earnings & Comprehensive







    Earnings  per share




    About Clemex Technologies, Inc.

    Clemex Technologies Inc. develops, manufactures and markets image analysis systems and software used by quality control and research microscopy laboratories. Clemex’s customer base spans the globe and encompasses prestigious Universities and Research Centers in many scientific domains, large and medium size manufacturing facilities in numerous industries including automotive, aerospace, raw materials manufacturing, pharmaceuticals, mining and other sectors.